Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of tapentadol prolonged-release for chronic osteoarthritis knee pain
2006-005783-67Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in knee osteoarthritis (OA) (3 arms), sponsored by Grünenthal GmbH. Primary endpoint: Change from baseline in average pain intensity over the 12-week maintenance period. Started Jan 2007; status: completed.
02
Drugs
tapentadol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-005783-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005783-67.